Roche’s Susvimo secures five-year efficacy and safety data in neovascular age-related macular degeneration (nAMD), potentially reshaping the treatment landscape...

Artelo Biosciences has secured positive scientific advice from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its...

Orchestra Biomed Secures $70M in Strategic Funding, Signaling Growing Confidence in Late-Stage Cardiology Programs Orchestra Biomed has secured $70...

Liminatus Pharma, a preclinical biopharmaceutical company, is making a striking move into the cryptocurrency market, planning to acquire up...

Bio Usawa and DEK Forge Partnership to Tackle Africa’s Growing Non-Communicable Disease Burden Bio Usawa, a private biotech company...

Branded Legacy, Inc., a diversified holdings company, is poised to enter the burgeoning naloxone and vaccine markets through a...

Vivex Biologics has completed patient enrollment in its ASCEND trial, a pivotal study evaluating VIA Disc NP, a novel...

EyePoint Pharmaceuticals has achieved full enrollment in its LUCIA trial, the second of two pivotal Phase 3 studies evaluating...

Serina Therapeutics is advancing SER-270 (POZ-VMAT2i), a once-weekly injectable vesicular monoamine transporter 2 (VMAT2) inhibitor, for tardive dyskinesia (TD)....

Bio Usawa and Sartorius Stedim Biotech Forge Partnership to Bolster Africa’s Biopharma Capabilities Bio Usawa, a Rwandan biotechnology company,...